Market Overview

UPDATE: Morgan Stanley Upgrades Becton Dickinson to Equal-Weight on Margin, Organic Growth

Share:
Related BDX
Earnings Scheduled For May 5, 2016
UPDATE: BD Announces Divestment of Vertebral Augmentation Solutions Business to Stryker; Terms Not Disclosed
Becton Dickinson: –9% EPS Growth With Good Dividends (GuruFocus)

Morgan Stanley raised its rating on Becton Dickinson (NYSE: BDX) from Underweight to Equal-weight and removed its price target of $68.

Morgan Stanley commented, "Upgrading BD to Equal-weight from Underweight. Organic growth and leverage are poised for a positive inflection after a two-year investment cycle. We are comfortable with valuation following 12% underperformance in 2012. To move to Overweight, we'd need better visibility on pipeline execution."

Becton Dickinson closed at $79.45 on Wednesday.

Latest Ratings for BDX

DateFirmActionFromTo
Feb 2016Deutsche BankUpgradesHoldBuy
Feb 2016CitigroupMaintainsNeutral
Jan 2016Evercore ISI GroupDowngradesBuyHold

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (BDX)

View Comments and Join the Discussion!